Meet inClinico: Transforming Clinical Trial Outcome Prediction Leveraging Artificial Intelligence
Researchers from Insilico Medicine designed and devised inClinico to predict Phase-II clinical trial outcomes. The transformer-based artificial intelligence software platform, inClinico, conjugates an ensemble of clinical trial outcome prediction (CTOP) engines that harness generative artificial intelligence and multimodal data that consolidates omics, text, clinical trial design, and small molecule properties. Integrating multimodal data sources, multiple…


















































